PTEN and neoplasm: Both PTEN altered models had little monotherapy sensitivity to fulvestrant but combining PI3Kαi with ER inhibition had modest anti-tumour effects that was attenuated relative to the combination with AKTi (Fig. 3C and Supplementary Fig. 1A).